Cradle’s Journey: Accelerating Drug Development with JLABS Support
Discover how JLABS empowers startups to accelerate breakthroughs in healthcare with the eyes of Stef van Grieken, CEO of Cradle. In a short video Stef shares how being part of the JLABS community has helped his company leverage cutting edge resources, connect with leading scientists and validate machine learning models – all while conserving valuable startup resources. If you want to join Cradle and become part of the JLABS community in Europe, connect with us today by following the guidance under Stef’s video.
Please click here for the video.
Scientists use Cradle to engineer better proteins through intelligent exploration of sequence space. By learning from every experimental data point, Cradle discovers novel sequences far beyond adjacent space and enables simultaneous optimization of multiple properties like stability, expression, and binding. With models continuously developed and validated in its Amsterdam wet lab and seamless integration with existing laboratory workflows, Cradle helps scientific teams significantly reduce the number of experimental rounds while increasing success rates – with users reporting 1.5x to 12x faster progress toward their protein engineering goals.
In this video, Cradle CEO, Stef van Grieken shares how being part of the JLABS community has helped his company leverage cutting edge resources, connect with leading scientists and validate machine learning models.
Since the interview, Cradle has had continued success and growth, raising another 73M Series B round, bringing their total funding to over $100M. Stay tuned for more updates about Cradle’s progress in upcoming updates from JLABS.
